Citigroup’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$296K Sell
29,754
-1,176
-4% -$10.5K ﹤0.01% 3807
2025
Q4
$262K Buy
30,930
+16,616
+116% +$119K ﹤0.01% 3871
2025
Q3
$74.7K Sell
14,314
-109,079
-88% -$416K ﹤0.01% 4366
2025
Q2
$427K Sell
123,393
-136,920
-53% -$407K ﹤0.01% 3720
2025
Q1
$682K Buy
260,313
+54,637
+27% +$214K ﹤0.01% 3510
2024
Q4
$847K Buy
205,676
+118,290
+135% +$644K ﹤0.01% 3483
2024
Q3
$619K Buy
87,386
+43,796
+100% +$327K ﹤0.01% 3594
2024
Q2
$284K Sell
43,590
-371,387
-89% -$2.54M ﹤0.01% 3711
2024
Q1
$3.44M Buy
414,977
+268,714
+184% +$2.62M ﹤0.01% 1994
2023
Q4
$1.61M Sell
146,263
-24,821
-15% -$209K ﹤0.01% 2431
2023
Q3
$1.44M Sell
171,084
-30,622
-15% -$329K ﹤0.01% 2235
2023
Q2
$2.53M Sell
201,706
-154,406
-43% -$1.92M ﹤0.01% 1998
2023
Q1
$5.87M Buy
356,112
+146,872
+70% +$2.63M 0.01% 1417
2022
Q4
$3.13M Buy
209,240
+27,462
+15% +$526K ﹤0.01% 1740
2022
Q3
$4.07M Sell
181,778
-4,380
-2% -$96.1K 0.01% 1660
2022
Q2
$3.12M Buy
186,158
+154,898
+496% +$3.32M ﹤0.01% 1794
2022
Q1
$936K Sell
31,260
-128,355
-80% -$3.11M ﹤0.01% 3035
2021
Q4
$4.9M Buy
159,615
+25,382
+19% +$802K ﹤0.01% 1846
2021
Q3
$4.23M Buy
134,233
+11,007
+9% +$371K ﹤0.01% 1935
2021
Q2
$4.51M Buy
123,226
+15,312
+14% +$505K ﹤0.01% 1985
2021
Q1
$3.73M Buy
107,914
+98,096
+999% +$4.26M ﹤0.01% 2019
2020
Q4
$408K Buy
9,818
+8,272
+535% +$374K ﹤0.01% 4385
2020
Q3
$66K Buy
+1,546
New +$58.9K ﹤0.01% 5410

Other funds holding RLAY